Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.8302619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Hai Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Mitochondria, Antineoplastic Agents, Fluorescent Dyes, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, National Natural Science Foundation of China, Korea Basic Science Institute.
Abstract (Originalsprache)
Mitochondrial damage induced by chemotherapeutic agents through disruption of the mitochondrial membrane potential (Δ Ψ m ) remains a central challenge in drug development and evaluation. However, the assessment of Δ Ψ m ‐targeting drugs using commercially available fluorescent probes is often unreliable, as these dyes can interfere with, mask, or artificially amplify drug‐induced mitochondrial dysfunction, frequently resulting in misleading conclusions and translational failure. Herein, we report a class of cationic chemotherapeutic small molecules ( DPPs ) possessing intrinsic fluorescence migration‐based self‐reporting capability, which enables direct and non‐invasive monitoring of drug action without the need for external probes. Among them, DPP‐1 and DPP‐2 disrupt mitochondrial function, trigger excessive reactive oxygen species generation, and induce highly selective apoptosis. Remarkably, both compounds exhibit concentration‐dependent mitochondrial‐to‐nuclear translocation, enabling the real‐time visualization of therapeutic progression at the subcellular level. In vivo studies further confirm their potent tumor growth inhibition and negligible systemic toxicity effects. This self‐reporting mitochondria‐targeted chemotherapeutic platform provides a highly promising strategy for integrated cancer diagnosis and precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.
- Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
- Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, P. R. China.
- School of Chemistry and Chemical Engineering, Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions, Henan Normal University, Henan, P. R. China.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.
ORCID-Profile: Hai Xu, Sanghee Yoon, Hua Zhang, Sun Choi, Ki Taek Nam, Juyoung Yoon
Förderung
- National Research Foundation of Korea
- National Natural Science Foundation of China
- Korea Basic Science Institute
Zitieren
APA
Xu, H., Lee, Y., Yoon, S., Wang, Y., Cho, Y., Choi, S., Lu, L., Zhang, H., Choi, S., Nam, K. T., & Yoon, J. (2026). Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.8302619
Vancouver
Xu H, Lee Y, Yoon S, Wang Y, Cho Y, Choi S, et al. Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.8302619
BibTeX
@article{Xu2026,
author = {Xu, Hai and Lee, Yura and Yoon, Sanghee and Wang, Yun and Cho, Yejin and Choi, Seongyu and Lu, Lu and Zhang, Hua and Choi, Sun and Nam, Ki Taek and Yoon, Juyoung},
title = {Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.8302619}
}
EUVIMED